During the past decade, Orange County Retina Medical Group conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 14 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 11 clinical trials were completed. i.e. 91.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orange County Retina Medical Group" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Kodiak Sciences Inc" with 3 trials sponsored, "Apellis Pharmaceuticals, Inc." with 2 trials sponsored, "Clearside Biomedical, Inc." with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orange County Retina Medical Group" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Duke University" with 1 trials as a collaborator, "National Eye Institute (NEI)" with 1 trials as a collaborator, "Parexel" with 1 trials as a collaborator and "Trial Runners, LLC" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Orange County Retina Medical Group" are "Diabetic Macular Edema" (5 trials), "Geographic Atrophy" (5 trials), "Macular Degeneration" (2 trials), "Macular Edema" (2 trials) and "Neovascular Age-Related Macular Degeneration" (2 trials). Many other conditions were trialed in "Orange County Retina Medical Group" in a lesser frequency.

Most popular intervention types in "Orange County Retina Medical Group" are "Drug" (28 trials), "Other" (9 trials), "Biological" (3 trials), "Procedure" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (11 trials), "Aflibercept" (6 trials), "Faricimab" (5 trials), "KSI-301" (3 trials) and "Ranibizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Orange County Retina Medical Group" are 32 trials for "All" genders.

Currently, there are NaN active trials in "Orange County Retina Medical Group". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Orange County Retina Medical Group, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Orange County Retina Medical Group, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".